Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease.

Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease.

Publication date: Sep 29, 2019

Norrbacka, S., Lindholm, D., and My”oh”anen, T.T. Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease. 06701. 2019 J Cell Mol Med.

Concepts Keywords
Huntington’s disease Aggregation
Prolyl endopeptidase
Oligopeptidase
Neurodegeneration
Huntingtin
Autophagy
Neurological disorders
Programmed cell death
Enzymes
Immunology
Branches of biology

Semantics

Type Source Name
gene UNIPROT HTT

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *